BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26366412)

  • 21. Candida and its dual lifestyle as a commensal and a pathogen.
    Cauchie M; Desmet S; Lagrou K
    Res Microbiol; 2017; 168(9-10):802-810. PubMed ID: 28263903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida albicans hyphal invasion: thigmotropism or chemotropism?
    Davies JM; Stacey AJ; Gilligan CA
    FEMS Microbiol Lett; 1999 Feb; 171(2):245-9. PubMed ID: 10077850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyphal growth in Candida albicans does not require induction of hyphal-specific gene expression.
    Naseem S; Araya E; Konopka JB
    Mol Biol Cell; 2015 Mar; 26(6):1174-87. PubMed ID: 25609092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth inhibition of Candida albicans by human vaginal epithelial cells.
    Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
    J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital anti-candida of human vaginal epithelial cells].
    Liu Zh; Chen L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):174-7. PubMed ID: 18458694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenicity of Candida albicans with particular reference to the vagina.
    Ryley JF
    J Med Vet Mycol; 1986 Feb; 24(1):5-22. PubMed ID: 3517278
    [No Abstract]   [Full Text] [Related]  

  • 27. Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology.
    Kasper L; Miramón P; Jablonowski N; Wisgott S; Wilson D; Brunke S; Hube B
    J Med Microbiol; 2015 Jul; 64(7):714-723. PubMed ID: 25976001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human oral keratinocyte E-cadherin degradation by Candida albicans and Candida glabrata.
    Pärnänen P; Meurman JH; Samaranayake L; Virtanen I
    J Oral Pathol Med; 2010 Mar; 39(3):275-8. PubMed ID: 20359311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of estrogen and normal flora on vaginal candidiasis in the rat.
    Larsen B; Galask RP
    J Reprod Med; 1984 Dec; 29(12):863-8. PubMed ID: 6394756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of virulence and changes in morphology in Candida albicans by disruption of the N-acetylglucosamine catabolic pathway.
    Singh P; Ghosh S; Datta A
    Infect Immun; 2001 Dec; 69(12):7898-903. PubMed ID: 11705974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of Lactobacillus as protector against vaginal candidiasis].
    Osset J; García E; Bartolomé RM; Andreu A
    Med Clin (Barc); 2001 Sep; 117(8):285-8. PubMed ID: 11571120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Candida albicans regulatory genes governing mucosal infection.
    Meir J; Hartmann E; Eckstein MT; Guiducci E; Kirchner F; Rosenwald A; LeibundGut-Landmann S; Pérez JC
    Cell Microbiol; 2018 Aug; 20(8):e12841. PubMed ID: 29575428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions.
    Consolaro ME; Gasparetto A; Svidzinski TI; Peralta RM
    Mycopathologia; 2006 Aug; 162(2):75-82. PubMed ID: 16897584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.
    Roselletti E; Perito S; Gabrielli E; Mencacci A; Pericolini E; Sabbatini S; Cassone A; Vecchiarelli A
    Sci Rep; 2017 Dec; 7(1):17877. PubMed ID: 29259175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida albicans: the estrogen target for vaginal colonization.
    Tarry W; Fisher M; Shen S; Mawhinney M
    J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Virulence factors of Candida albicans].
    Staniszewska M; Bondaryk M; Piłat J; Siennicka K; Magda U; Kurzatkowski W
    Przegl Epidemiol; 2012; 66(4):629-33. PubMed ID: 23484392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
    Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylglucosamine (GlcNAc) induction of hyphal morphogenesis and transcriptional responses in Candida albicans are not dependent on its metabolism.
    Naseem S; Gunasekera A; Araya E; Konopka JB
    J Biol Chem; 2011 Aug; 286(33):28671-28680. PubMed ID: 21700702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and genotypic characteristics of Candida albicans isolates from bloodstream and mucosal infections.
    Mandelblat M; Frenkel M; Abbey D; Ben Ami R; Berman J; Segal E
    Mycoses; 2017 Aug; 60(8):534-545. PubMed ID: 28543785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.